Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TMCI | Common Stock | Options Exercise | $2.5K | +25K | +250.63% | $0.10* | 35K | Nov 14, 2022 | Direct | F1, F2 |
transaction | TMCI | Common Stock | Sale | -$607K | -25K | -71.48% | $24.27 | 9.98K | Nov 14, 2022 | Direct | F1, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TMCI | Stock Option (Right to Buy) | Options Exercise | -$2.5K | -25K | -18.69% | $0.10* | 109K | Nov 14, 2022 | Common Stock | 25K | $0.10 | Direct | F1 |
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F2 | Includes 9,975 RSUs. |
F3 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.8000 to $24.5500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |